正电子发射断层显像评估心肌存活:基本概念、文献简要综述及一家三级PET中心的经验
缺血性心力衰竭中可逆的冬眠心肌概念促使术前存活评估需求增加,但临床检测冬眠心肌尚无共识。多种影像方法(基于形态、灌注和/或代谢)被用于评估冬眠心肌,PARR-2试验及其亚组研究提示冬眠心肌>5%时血运重建优于优化药物治疗。本文综述PET评估心肌冬眠的基本概念与现有证据,讨论灌注/代谢PET图像处理方法,并介绍一家三级转诊中心的PET存活评估经验。
要点
- 冬眠心肌指严重灌注减低但仍存活、血运重建后可逆的功能减低状态。
- PARR-2试验及亚组研究提示冬眠心肌>5%时血运重建优于优化药物治疗。
- 临床检测冬眠心肌尚无共识,现有影像方法包括基于形态、灌注和/或代谢的多种技术。
核心结论
- 冬眠心肌概念被广泛认同,但临床检测冬眠心肌尚无共识。
- 关于术前存活评估对血运重建影响的前瞻性临床试验很少。
- PARR-2试验及亚组研究提示冬眠心肌>5%时血运重建优于优化药物治疗。
研究设计与样本
- 本文为综述,纳入基本概念、文献简要综述、PET图像处理方法及一家三级转诊中心的PET存活评估经验。
主要发现
- 缺血性心脏病可从灌注轻度减低而收缩功能保留进展至冠状动脉慢性闭塞、心肌细胞被无收缩性瘢痕组织替代的缺血性心力衰竭。
- 向瘢痕组织进展被认为经历一个心肌细胞无收缩但仍存活、灌注严重减低的阶段,即冬眠。
- 评估冬眠的影像方法包括基于形态的MRI和超声、基于灌注的MRI、SPECT或PET,以及评估心肌代谢的PET。
- 关于该主题的文献异质性大,设计用于评估血运重建前存活检测影响的前瞻性临床试验很少。
- PARR-2试验及亚组研究提示冬眠心肌>5%时血运重建优于优化药物治疗。
关键数值与推荐
- PARR-2试验及亚组研究提示冬眠心肌>5%时血运重建优于优化药物治疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 关于该主题的文献异质性大,设计用于评估血运重建前存活检测影响的前瞻性临床试验很少。
- 临床检测冬眠心肌尚无共识。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ischemic heart disease ranges in severity from slightly reduced myocardial perfusion with preserved contractile function to chronic occlusion of coronary arteries with myocardial cells replaced by acontractile scar tissue-ischemic heart failure (iHF). Progression towards scar tissue is thought to involve a period in which the myocardial cells are acontractile but still viable despite severely reduced perfusion. This state of reduced myocardial function that can be reversed by revascularization is termed "hibernation." The concept of hibernating myocardium in iHF has prompted an increasing amount of requests for preoperative patient workup, but while the concept of viability is widely agreed upon, no consensus on clinical testing of hibernation has been established. Therefore, a variety of imaging methods have been used to assess hibernation including morphology based (MRI and ultrasound), perfusion based (MRI, SPECT, or PET) and/or methods to assess myocardial metabolism (PET). Regrettably, the heterogeneous body of literature on the subject has resulted in few robust prospective clinical trials designed to assess the impact of preoperative viability testing prior to revascularization. However, the PARR-2 trial and sub-studies has indicated that >5% hibernating myocardium favors revascularization over optimized medical therapy. In this paper, we review the basic concepts and current evidence for using PET to assess myocardial hibernation and discuss the various methodologies used to process the perfusion/metabolism PET images. Finally, we present our experience in conducting PET viability testing in a tertiary referral center.
引用
- Madsen S, Dias AH, Lauritsen KM, et al. Myocardial Viability Testing by Positron Emission Tomography: Basic Concepts, Mini-Review of the Literature and Experience From a Tertiary PET Center. Semin Nucl Med. 2020. PMID: 32284111. doi:10.1053/j.semnuclmed.2020.02.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。